title: Congestive heart failure and VVI pacing mode: dynamic behavior of the dispersion of ventricular repolarization.
abstract: Dynamic Behavior of the Dispersion of Ventricular Repolarization. The aim of this study was to evaluate the circadian variation in the spatial dispersion of ventricular repolarization in continuously paced patients with congestive heart failure (CHF). Fourteen patients (10 males, 4 females, aged 65 +/- 8 years) with CHF due to dilated cardiomyopathy (DCM) and an echocardiographic ejection fraction of 28% +/- 3% were studied. All patients underwent AV junctional RF ablation and permanent pacemaker implantation for drug refractory chronic atrial fibrillation (AF). Patients were evaluated at 1 month postimplant with a three-channel 24-hour Holter monitor, using the three plane Frank orthogonal leads (X, Y, and Z), in VVI pacing mode at 70 beats/min. For each hour, the mean value of spike-T interval dispersion of the first five beats was measured. The control group consisted of 20 patients without structural heart disease, but with AF and complete AV block, continuously paced in VVI mode at 70 beats/min. The dispersion of the spike-T interval had a circadian behavior in the study population, with higher values at night and lower during the daytime. During the daytime, the mean value of spike-T interval dispersion was 39 +/- 5 ms and during the nighttime it was 45 +/- 7 ms (P = 0.003). Such a difference between day and night was not found in the control group (38 +/- 6 ms and 40 +/- 8 ms, respectively, P = NS). In the daytime period the mean value of spike-T interval dispersion of our study population was comparable to that of the control group (P = NS), while during the nighttime it was significantly higher (P = 0.0004). In conclusion, by evaluating the dispersion of ventricular repolarization in two dimensions, space and time, a circadian variation was found in paced patients with CHF due to DCM. The increased QT dispersion in these patients during the nighttime period was attributed to different effects of vagal activity in normal and abnormal myocardial areas.
authors.affiliation: Hellenic Red Cross Hospital, Athens, Greece.
authors.forename: A G
authors.initials: AG
authors.lastname: Manolis
authors.forename: A
authors.initials: A
authors.lastname: Katsivas
authors.forename: D
authors.initials: D
authors.lastname: Koutsogeorgis
authors.forename: A
authors.initials: A
authors.lastname: Theodorakis
authors.forename: G
authors.initials: G
authors.lastname: Apostolopoulos
authors.forename: P
authors.initials: P
authors.lastname: Nikolaou
authors.forename: N
authors.initials: N
authors.lastname: Louvros
mesh_terms: D000368:Aged; D001281:Atrial Fibrillation / Q000601:surgery / Q000628:therapy; D001283:Atrioventricular Node / Q000601:surgery; D002304:Cardiac Pacing, Artificial / Q000379:methods*; D002311:Cardiomyopathy, Dilated / Q000150:complications; D017115:Catheter Ablation; D002908:Chronic Disease; D002940:Circadian Rhythm; D004452:Echocardiography; D015716:Electrocardiography, Ambulatory; D005260:Female; D006327:Heart Block / Q000601:surgery / Q000628:therapy; D006333:Heart Failure / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010138:Pacemaker, Artificial; D013318:Stroke Volume; D014630:Vagus Nerve / Q000503:physiopathology; D016276:Ventricular Function